BPC 157 is a very interesting and potentially promising substance. However, in research, it demonstrates effects that are the opposite of your requests, as far as I understood. Thus, BPC 157 may counteract the consequences of dopamine-related nigrostriatal neuronal damage, dopamine vesicle depletion, dopamine receptors blockade, and the consequences of reduced dopaminergic activity. All these notions suggest a special interaction of gastric peptide with dopaminergic system and an ability of BPC 157 to counteract the effect of a noxious agent within the central dopaminergic system and through dopamine, the interaction with other systems as well. In addition, BPC 157 acts on other neurotransmitter systems. It is difficult to predict how your neurochemistry will react to taking it.